跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ERLOTINIB TILLOMED 150 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
ERLOTINIB TILLOMED 150 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Approved
STANDARD
ERLOTINIB TILLOMED 150 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Laboratorios Tillomed Spain S.L.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Apr 5, 2022
Approval ID
ec4cb93b5ae6503a
Company
Laboratorios Tillomed Spain S.L.
Type
Standard
Approval Details
Approval Id
ec4cb93b5ae6503a
Drug Cima Aemps Name
ERLOTINIB TILLOMED 150 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Register Number
85933
Holder Company Name
Laboratorios Tillomed Spain S.L.
Marketing Company Name
Laboratorios Tillomed Spain S.L.
Authorization Date
2022-04-05
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
150 mg
Route Of Administration
VÍA ORAL
Prescription Type
Diagnóstico Hospitalario
Commercialized
No
Company Name
Laboratorios Tillomed Spain S.L.
Active Ingredients
ERLOTINIB HIDROCLORURO
163,9 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Apr 5, 2022
Approval ID
ec4cb93b5ae6503a
Type
Standard
Back to CIMA-AEMPS Approvals